Table: begin end state 1 40 cytoplasmic 41 58 transmembrane 59 66 non-cytoplasmic 67 88 transmembrane 89 98 cytoplasmic 99 117 transmembrane 118 122 non-cytoplasmic 123 144 transmembrane 145 165 cytoplasmic 166 187 transmembrane 188 198 non-cytoplasmic 199 218 transmembrane 219 248 cytoplasmic 249 267 transmembrane 268 285 non-cytoplasmic 286 304 transmembrane 305 314 cytoplasmic 315 334 transmembrane 335 339 non-cytoplasmic 340 364 transmembrane 365 375 cytoplasmic 376 397 transmembrane 398 408 non-cytoplasmic 409 427 transmembrane 428 439 cytoplasmic
Input: >Pf1N1B4_686 MDNSNTLPLGSAALPVKEKTTASRIKSIFSGSVGNMVEWYDWYVYAAFSLYFAKTFFPAG SSTAQLMNTAAIFAVGFLMRPIGGWLMGLYADRAGRKRALMASVYLMCFGSLLIALSPNY ETIGIGAPILLVFARLLQGLSVGGEYGTSATYLSEMATKERRGFYSSFQYVTLISGQLIA LAVLIVLQQTLTTEQLYAWGWRIPFAIGALCAVVALYLRRGMEETESFTKKVKAKESAMR TLMRHPKELMTVVGLTMGGTLAFYTYTTYMQKYLVNTVGMSITDSTSISAATLFLFMCLQ PIVGGLSDKVGRRPILIAFGILGTLFTVPILTTLHTVQTWWGAFFLIMAALIIVSGYTSI NAVVKAELFPTEIRALGVGLPYALTVSIFGGTAEYIALWFKSIGMETGYYWYVTACIAVS LLVYITMKDTRKHSRIETD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server